Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
GlucoTrack, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
GCTK
Nasdaq
3840
glucotrack.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for GlucoTrack, Inc.
Glucotrack Prices $3 Million Public Offering to Fund Expansion
- Feb 5th, 2025 4:52 pm
Glucotrack hits trial success for direct blood measuring CGM
- Feb 4th, 2025 6:44 pm
Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering
- Feb 4th, 2025 5:24 pm
Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
- Feb 4th, 2025 1:01 pm
Glucotrack Announces Reverse Stock Split
- Jan 30th, 2025 1:00 pm
Glucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer
- Jan 29th, 2025 2:00 pm
Glucotrack Announces ISO 13485:2016 Certification
- Jan 21st, 2025 1:01 pm
Glucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs
- Jan 15th, 2025 1:01 pm
Glucotrack to Present at TechBio Showcase™ 2025
- Jan 7th, 2025 9:05 pm
GLUCOTRACK ANNOUNCES START OF ENROLLMENT FOR HUMAN CLINICAL STUDY OF CONTINUOUS BLOOD GLUCOSE MONITOR
- Dec 3rd, 2024 1:30 pm
Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt
- Nov 14th, 2024 9:30 pm
Glucotrack, Inc. Announces Pricing of $10.0 Million Public Offering
- Nov 13th, 2024 2:00 pm
GLUCOTRACK TO PRESENT AT 2024 BIOFUTURE CONFERENCE
- Oct 22nd, 2024 1:00 pm
GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING
- Oct 1st, 2024 1:00 pm
JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS
- Sep 3rd, 2024 1:00 pm
GLUCOTRACK ANNOUNCES NEW VICE PRESIDENT OF CLINICAL OPERATIONS
- Aug 27th, 2024 1:00 pm
Glucotrack’s Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference
- Aug 15th, 2024 1:00 pm
GLUCOTRACK ANNOUNCES POSTER PRESENTATION ON CONTINUOUS BLOOD GLUCOSE MONITOR SURVEY DATA AT THE ASSOCIATION OF DIABETES CARE AND EDUCATION SPECIALISTS (ADCES) 2024 ANNUAL CONFERENCE
- Aug 5th, 2024 1:00 pm
GLUCOTRACK ANNOUNCES NEW FUNDING FOR DEVELOPMENT OF ITS CONTINUOUS BLOOD GLUCOSE MONITOR
- Jul 31st, 2024 8:00 pm
GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ANDY BALO TO BOARD OF DIRECTORS
- Jun 20th, 2024 12:30 pm
Scroll